DK2427449T3 - Vinylindazolylforbindelser - Google Patents

Vinylindazolylforbindelser

Info

Publication number
DK2427449T3
DK2427449T3 DK10717402.1T DK10717402T DK2427449T3 DK 2427449 T3 DK2427449 T3 DK 2427449T3 DK 10717402 T DK10717402 T DK 10717402T DK 2427449 T3 DK2427449 T3 DK 2427449T3
Authority
DK
Denmark
Prior art keywords
vinylindazolyl
compounds
vinylindazolyl compounds
Prior art date
Application number
DK10717402.1T
Other languages
English (en)
Inventor
Daohong Chen
Hong-Yu Li
Genshi Zhao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2427449T3 publication Critical patent/DK2427449T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK10717402.1T 2009-05-07 2010-05-04 Vinylindazolylforbindelser DK2427449T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17629009P 2009-05-07 2009-05-07
US30141610P 2010-02-04 2010-02-04
PCT/US2010/033487 WO2010129509A1 (en) 2009-05-07 2010-05-04 Vinyl indazolyl compounds

Publications (1)

Publication Number Publication Date
DK2427449T3 true DK2427449T3 (da) 2013-04-22

Family

ID=42238704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10717402.1T DK2427449T3 (da) 2009-05-07 2010-05-04 Vinylindazolylforbindelser

Country Status (34)

Country Link
US (1) US8268869B2 (da)
EP (1) EP2427449B1 (da)
JP (1) JP5555314B2 (da)
KR (1) KR101373910B1 (da)
CN (1) CN102421769B (da)
AR (1) AR078411A1 (da)
AU (1) AU2010246114B2 (da)
BR (1) BRPI1013748A2 (da)
CA (1) CA2760535C (da)
CL (1) CL2011002781A1 (da)
CO (1) CO6450624A2 (da)
CR (1) CR20110580A (da)
DK (1) DK2427449T3 (da)
EA (1) EA018149B1 (da)
EC (1) ECSP11011441A (da)
ES (1) ES2408117T3 (da)
HN (1) HN2011002809A (da)
HR (1) HRP20130323T1 (da)
IL (1) IL216004A (da)
JO (1) JO2860B1 (da)
MA (1) MA33244B1 (da)
ME (1) ME01462B (da)
MX (1) MX2011011342A (da)
MY (1) MY160390A (da)
NZ (1) NZ595553A (da)
PE (2) PE20120812A1 (da)
PL (1) PL2427449T3 (da)
PT (1) PT2427449E (da)
RS (1) RS52795B (da)
SG (1) SG175909A1 (da)
SI (1) SI2427449T1 (da)
TW (1) TWI382982B (da)
UA (1) UA104756C2 (da)
WO (1) WO2010129509A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3062B1 (ar) * 2010-10-05 2017-03-15 Lilly Co Eli R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
KR20220017512A (ko) 2012-03-08 2022-02-11 아스테라스 세이야쿠 가부시키가이샤 신규 fgfr3 융합체
CA2876689C (en) 2012-06-13 2022-04-26 Incyte Corporation Substituted tricyclic compounds as fgfr inhibitors
US20150203589A1 (en) 2012-07-24 2015-07-23 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
WO2014151734A1 (en) 2013-03-15 2014-09-25 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
PH12015502383B1 (en) 2013-04-19 2023-02-03 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
CN103819396B (zh) * 2014-02-26 2016-06-15 四川大学 一种手性的1-（3,5-二氯吡啶-4-基）-乙醇的合成方法
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3925979A3 (en) 2014-12-23 2022-03-23 The Trustees of Columbia University in the City of New York Fgfr-tacc fusion proteins and methods thereof
CA2976790C (en) 2015-02-20 2024-02-27 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
CN105906621A (zh) * 2015-04-06 2016-08-31 四川百利药业有限责任公司 用作fgfr抑制剂的乙醇类化合物
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
EP3333157B1 (en) * 2015-08-07 2020-12-23 Harbin Zhenbao Pharmaceutical Co., Ltd. Vinyl compounds as fgfr and vegfr inhibitors
CN107406431B (zh) 2015-08-20 2020-06-26 上海昂睿医药技术有限公司 吲哚类衍生物及其制备方法和其在医药上的用途
CN107459519A (zh) 2016-06-06 2017-12-12 上海艾力斯医药科技有限公司 稠合嘧啶哌啶环衍生物及其制备方法和应用
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
KR102956194B1 (ko) 2018-05-04 2026-04-23 인사이트 코포레이션 Fgfr 억제제의 염
RS66310B1 (sr) 2018-05-04 2025-01-31 Incyte Corp Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
GEP20247679B (en) 2019-10-14 2024-10-10 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN114072387B (zh) * 2019-11-06 2024-03-08 暨南大学 吲唑类化合物及其药用组合物和应用
MX2022006691A (es) 2019-12-04 2022-09-19 Incyte Corp Derivados de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr).
WO2021113479A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021138391A1 (en) * 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN113666911B (zh) * 2020-08-11 2025-08-26 河南迈英诺医药科技有限公司 Fgfr抑制剂化合物及其用途
EP4323405A1 (en) 2021-04-12 2024-02-21 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220274A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202313610A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為ｆｇｆｒ抑制劑之三環雜環
CN116554148B (zh) * 2022-12-13 2025-01-28 药康众拓(北京)医药科技有限公司 一种乙烯基吲唑类氘代fgfr抑制剂药物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
BRPI0113757B8 (pt) 2000-09-11 2017-11-07 Chiron Corp derivados de quinolinona como inibidores de tirosina quinase
JP4383870B2 (ja) * 2001-10-17 2009-12-16 協和発酵キリン株式会社 線維芽細胞増殖因子受容体自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
CN1656079A (zh) * 2002-05-31 2005-08-17 卫材株式会社 吡唑化合物和含有该化合物的药物组合物
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
EP1753763B1 (en) 2004-05-26 2008-08-13 Pfizer Limited Indazole and indolone derivatives and their use as pharmaceuticals
WO2007058626A1 (en) 2005-11-16 2007-05-24 S*Bio Pte Ltd Indazole compounds
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
WO2008074749A1 (en) 2006-12-20 2008-06-26 Nerviano Medical Sciences S.R.L. Indazole derivatives as kinase inhibitors for the treatment of cancer
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
AR068046A1 (es) 2007-06-05 2009-11-04 Schering Corp Derivados policiclicos de indazol y su uso como inhibidores de erk para el tratamiento del cancer
DE102007028521A1 (de) 2007-06-21 2008-12-24 Merck Patent Gmbh Indazolamidderivate
JP2011511005A (ja) * 2008-02-04 2011-04-07 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド ２−アミノピリジン系キナーゼ阻害薬

Also Published As

Publication number Publication date
TW201105652A (en) 2011-02-16
NZ595553A (en) 2013-05-31
US8268869B2 (en) 2012-09-18
PE20120812A1 (es) 2012-07-08
JP2012526126A (ja) 2012-10-25
PT2427449E (pt) 2013-05-06
EA201171367A1 (ru) 2012-04-30
UA104756C2 (uk) 2014-03-11
BRPI1013748A2 (pt) 2016-04-05
MY160390A (en) 2017-03-15
CN102421769A (zh) 2012-04-18
EA018149B1 (ru) 2013-05-30
AU2010246114B2 (en) 2012-12-06
CN102421769B (zh) 2014-04-02
CL2011002781A1 (es) 2012-05-25
AU2010246114A1 (en) 2011-11-03
AR078411A1 (es) 2011-11-09
ME01462B (me) 2014-04-20
CR20110580A (es) 2012-01-06
CO6450624A2 (es) 2012-05-31
TWI382982B (zh) 2013-01-21
ES2408117T3 (es) 2013-06-18
CA2760535C (en) 2014-01-14
RS52795B (sr) 2013-10-31
KR101373910B1 (ko) 2014-03-12
JO2860B1 (en) 2015-03-15
PL2427449T3 (pl) 2013-08-30
HN2011002809A (es) 2013-07-22
PE20160124A1 (es) 2016-02-24
SG175909A1 (en) 2011-12-29
IL216004A (en) 2014-01-30
EP2427449A1 (en) 2012-03-14
MA33244B1 (fr) 2012-05-02
WO2010129509A1 (en) 2010-11-11
HRP20130323T1 (en) 2013-05-31
EP2427449B1 (en) 2013-04-03
ECSP11011441A (es) 2011-12-30
IL216004A0 (en) 2012-01-31
HK1163665A1 (en) 2012-09-14
MX2011011342A (es) 2011-11-18
US20100286209A1 (en) 2010-11-11
JP5555314B2 (ja) 2014-07-23
SI2427449T1 (sl) 2013-05-31
KR20120004511A (ko) 2012-01-12
CA2760535A1 (en) 2010-11-11

Similar Documents

Publication Publication Date Title
CY2017026I1 (el) Τετρακυκλικη ενωση
SMT201600008B (it) Composti di piridazinone
BR112012006859A2 (pt) compostos
PT2506716T (pt) Novos compostos tricíclicos
BRPI1008774A2 (pt) espiroamida substituída
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
DK2414015T3 (da) Laryngoskopsystem
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
BRPI1005525A2 (pt) compostos de azaazuleno
EP2440486A4 (en) CABLE RETRACTION SYSTEM
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1013868A2 (pt) composto diaciletilenodiamina
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
UY33156A (es) Nuevos compuestos tienopirrol
DE112010002728A5 (de) Turboinhalator
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
EP2409976A4 (en) GLYCINE TRANSPORTER INHIBITOR
DK2483126T3 (da) Skinnekøretøj